Effect of Oleic Acid on Inflammation Markers and Blood Lipid Metabolites: A Randomised, Double-Blind, Crossover Study

Not Applicable

Completed

• Conditions: Inflammation
• Interventions: Other: Novel Olein

• Registration Number: NCT00715312
• Lead Sponsor: Malaysia Palm Oil Board

Brief Summary

Rationale: The effect of positional distribution of dietary fatty acids on markers of inflammation and blood lipids metabolites on diets containing fatty acids such as oleic acid that are associated with reduced risk of cardiovascular disease is not widely studied.

Hypothesis: There would be difference detected in the concentrations of markers of inflammation and blood lipid metabolites in human volunteers fed controlled diets.

Study design: A randomized, double-blind, crossover clinical trial that involves 41 healthy volunteers. The volunteers will be selected based on inclusion and exclusion criteria. They will consume controlled diets for 5 weeks that provides 15% of energy from protein, 30% of energy from fat, and 55% of energy from carbohydrates. Volunteers will be assigned to each test diets which is cooked with novel olein, palm stearin or partially hydrogenated soybean oil in random order until all three diets has consumed by each person.

Main study parameters: LDL-cholesterol

Detailed Description

Not available

Study Timeline

• Study Start: 2008-02
• Primary Completion: 2008-06
• Study Completion: 2008-06
• Status Verified: 2008-07
• Study First Submitted: 2008-07-11
• Study First Submitted QC: 2008-07-14
• Last Update Submitted: 2008-07-14
• Study First Posted: 2008-07-15
• Last Update Posted: 2008-07-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 43

Inclusion Criteria

• Healthy and free from any disease and absence of family history for arteriosclerosis or hypertension
• Not on any medication or supplements or weight loss program
• Non smokers and alcoholics

Exclusion Criteria

• Having some health-related problems e.g fever, flu, allergy, chronic diseases
• On some treatment or medication
• Smokers and alcoholics

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
A	Novel Olein	-

Primary Outcome Measures

Name	Time	Method
LDL-cholesterol	5 weeks

Secondary Outcome Measures

Name	Time	Method
C-reactive protein	5 weeks

Trial Locations

Locations (1)

Malaysia Palm Oil Board; 🇲🇾 Kajang, Selangor, Malaysia